North America - United States • M&A/corporate and commercial
Gunderson Dettmer LLP
Gunderson Dettmer LLP is highly reputed in the venture capital and emerging companies space, advising clients in cutting-edge industries, including its representation of Colossal Biosciences in a $150m Series B financing round led by the United States Innovative Technology Fund. Leading the entrepreneurs and emerging companies practice from Boston, Marc Dupre serves a wide range of clients, including entrepreneurs, start-ups, and venture capital investors. In New York, Kenneth McVay specializes in advising emerging companies within the media, software, finance, and e-commerce industries. Ivan Gaviria, based in Silicon Valley, focuses on representing venture capital-backed tech companies throughout their growth stages. Founding partners Robert Gunderson and Scott Dettmer are no longer active within the firm.
Legal 500 Editorial commentary
Work highlights
- Represented Flexport in its acquisition of Deliverr.
- Represented TeneoTwo in its acquisition by AstraZeneca.
- Represented Our Next Energy (ONE) in its $300m Series B financing led by Fifth Wall and Franklin Templeton.
Practice head
The lawyer(s) leading their teams.
Marc Dupre